|
Market Closed -
Euronext Paris
09:25:00 01/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 73.10 EUR | +0.63% |
|
+1.39% | -11.63% |
| 02/10 | Healthcare Stocks Among Top Losers -- Healthcare Roundup | DJ |
| 01/10 | US FDA advisers recommend flu vaccine strains for 2027 Southern Hemisphere season | RE |
Company Valuation: Sanofi
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,11,194 | 1,12,665 | 1,12,549 | 1,16,968 | 1,00,655 | 87,579 | - | - |
| Change | - | 1.32% | -0.1% | 3.93% | -13.95% | -12.99% | - | - |
| Enterprise Value (EV) 1 | 1,21,177 | 1,19,102 | 1,20,342 | 1,25,740 | 1,11,663 | 99,042 | 95,915 | 92,468 |
| Change | - | -1.71% | 1.04% | 4.49% | -11.2% | -11.3% | -3.16% | -3.59% |
| P/E | 17.8x | 16.7x | 20.8x | 20.4x | 12.9x | 11.6x | 10.1x | 8.76x |
| PBR | 1.62x | 1.5x | 1.52x | 1.51x | 1.41x | 1.18x | 1.12x | 1.05x |
| PEG | - | 2.07x | -1.1x | 3.14x | 0.3x | -6.14x | 0.7x | 0.6x |
| Capitalization / Revenue | 2.94x | 2.62x | 2.61x | 2.85x | 2.31x | 1.84x | 1.73x | 1.65x |
| EV / Revenue | 3.21x | 2.77x | 2.79x | 3.06x | 2.56x | 2.08x | 1.89x | 1.74x |
| EV / EBITDA | 9.95x | 8.14x | 8.44x | 9.76x | 8.22x | 6.72x | 6.12x | 5.44x |
| EV / EBIT | 11.3x | 9.13x | 9.5x | 11.1x | 9.19x | 7.44x | 6.85x | 6.11x |
| EV / FCF | 15x | 14x | 14.2x | 21.1x | 13.8x | 11.9x | 10.6x | 9.19x |
| FCF Yield | 6.68% | 7.12% | 7.04% | 4.74% | 7.24% | 8.39% | 9.39% | 10.9% |
| Dividend per Share 2 | 3.33 | 3.56 | 3.76 | 3.92 | 4.12 | 4.254 | 4.496 | 4.795 |
| Rate of return | 3.76% | 3.96% | 4.19% | 4.18% | 4.98% | 5.82% | 6.15% | 6.56% |
| EPS 2 | 4.97 | 5.37 | 4.31 | 4.59 | 6.4 | 6.279 | 7.206 | 8.348 |
| Distribution rate | 67% | 66.3% | 87.2% | 85.4% | 64.4% | 67.7% | 62.4% | 57.4% |
| Net sales 1 | 37,761 | 42,997 | 43,070 | 41,081 | 43,626 | 47,648 | 50,644 | 53,167 |
| EBITDA 1 | 12,183 | 14,627 | 14,259 | 12,889 | 13,583 | 14,728 | 15,673 | 16,990 |
| EBIT 1 | 10,714 | 13,040 | 12,670 | 11,343 | 12,149 | 13,312 | 13,999 | 15,142 |
| Net income 1 | 6,223 | 6,720 | 5,400 | 5,744 | 7,813 | 7,479 | 8,886 | 10,309 |
| Net Debt 1 | 9,983 | 6,437 | 7,793 | 8,772 | 11,008 | 11,463 | 8,336 | 4,889 |
| Reference price 2 | 88.58 | 89.84 | 89.76 | 93.74 | 82.72 | 73.10 | 73.10 | 73.10 |
| Nbr of stocks (in thousands) | 12,55,293 | 12,54,060 | 12,53,891 | 12,47,793 | 12,16,810 | 11,98,069 | - | - |
| Announcement Date | 04/02/22 | 03/02/23 | 01/02/24 | 30/01/25 | 29/01/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 11.57x | 2.07x | 6.69x | 5.86% | 9.88TCr | |
| 32.9x | 11.93x | 24.23x | 0.6% | 1,03100Cr | |
| 29.45x | 6.54x | 18.31x | 2.02% | 64TCr | |
| 33.1x | 7.75x | 16.02x | 2.65% | 46TCr | |
| 105.72x | 5.91x | 25.05x | 2.35% | 36TCr | |
| 19x | 4.63x | 11.48x | 2.87% | 33TCr | |
| 20.37x | 5.28x | 13.08x | 3.03% | 27TCr | |
| 20.79x | 4.31x | 12.28x | 2.05% | 25TCr | |
| 26.62x | 6.92x | 12.32x | 2.39% | 23TCr | |
| -45.08x | 6.57x | 25.65x | 2.21% | 18TCr | |
| Average | 25.44x | 6.19x | 16.51x | 2.6% | 38.63TCr | |
| Weighted average by Cap. | 31.58x | 7.57x | 18.59x | 2.02% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SAN Stock
- Valuation Sanofi
Select your edition
All financial news and data tailored to specific country editions
